Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder — Stella

Home/Attention Deficit Disorder With Hyperactivity/Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder

View on ClinicalTrials.gov

Recruiting

Back to Attention Deficit Disorder With Hyperactivity trials

Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Brazil

Program on Attention-Deficit/Hyperactivity Disorder (PRODAH); Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul

Key details

Phase

Post-approval study

Sponsor

Hospital de Clinicas de Porto Alegre

Collaborators

Federal University of Rio Grande do Sul, Conselho Nacional de Desenvolvimento Científico e Tecnológico

Enrollment target

~600 participants

Started

February 2002

Primary completion

December 2032

Age range

18 Years and older

Last updated November 2016

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.